Maravai Lifesciences HOLDINGS, Inc. (MRVI) intrinsic value & 10-year financials
Maravai Lifesciences HOLDINGS, Inc. (MRVI) has a Graham intrinsic value of $25.04 per share. At $6.79 on Oct 17, 2026, the stock trades 73% below that value. Over the last 8 fiscal years revenue grew 4.4% a year to $185.7M, with an average return on invested capital of 21.4%.
- Graham intrinsic value
- $25.04
- Share price (Oct 17, 2026)
- $6.79
- Price vs Graham value
- 73% below
- Market cap
- $980.2M
- Revenue (FY2025)
- $185.7M
- Revenue growth (8-yr CAGR)
- 4.4%
- ROIC (10-yr avg)
- 21.4%
- Free cash flow (FY2025)
- -$70.7M
MRVI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $185.7M | -$130.8M | -$0.90 | -$70.7M | -115.9% | -57.7% |
| FY2024 | $259.2M | -$144.8M | -$1.05 | -$22.2M | -90.9% | -57.0% |
| FY2023 | $288.9M | -$119.0M | -$0.90 | $60.7M | -11.0% | -3.4% |
| FY2022 | $883.0M | $220.2M | $1.67 | $518.9M | 65.0% | 108.7% |
| FY2021 | $799.2M | $182.0M | $1.56 | $353.7M | 69.4% | 114.7% |
| FY2020 | $284.1M | $89.0M | $0.26 | $126.8M | 42.2% | 30.0% |
| FY2019 | $143.1M | -$4.5M | -$0.00 | $7.0M | 16.8% | 14.5% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
MARAVAI LIFESCIENCES HOLDINGS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
MARAVAI LIFESCIENCES HOLDINGS, INC. has earned high returns on invested capital, averaging 21.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
MARAVAI LIFESCIENCES HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, MARAVAI LIFESCIENCES HOLDINGS, INC. is modeled at 4.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $25.04 per share.